Back to Search
Start Over
O4‐11‐05: A PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLASMA REPLACEMENT WITH 5% ALBUMIN IN BETA‐AMYLOID PEPTIDE CLEARANCE IN CEREBROSPINAL FLUID, AND ITS EFFECTS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER'S DISEASE
- Source :
- Alzheimer's & Dementia. 10
- Publication Year :
- 2014
- Publisher :
- Wiley, 2014.
- Subjects :
- chemistry.chemical_classification
medicine.medical_specialty
Amyloid
Epidemiology
business.industry
Health Policy
Albumin
Phases of clinical research
Peptide
Disease
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Cerebrospinal fluid
Endocrinology
Developmental Neuroscience
chemistry
Internal medicine
Medicine
In patient
Neurology (clinical)
Geriatrics and Gerontology
business
Beta (finance)
Subjects
Details
- ISSN :
- 15525279 and 15525260
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- Alzheimer's & Dementia
- Accession number :
- edsair.doi...........6c59c98015cd225ae9d7ba5180837d61